1
Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Pathway Discoveries and Their Potential for Treatment of Non-Small Cell Lung Cancer, Metastatic Melanoma, and Glioblastoma by Scientific Co-founder
March 09, 2023 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, March 09, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA). Ocean Biomedical’s Scientific Co-founder, Dr. Jack A. Elias, MD, presented details of his previously...
Dr. Raymond Osarogiagbon
Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
March 09, 2023 08:00 ET | Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
Immuneering-logo (1).png
Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 06, 2023 16:05 ET | Immuneering Corporation
First patient dosed in Phase 1/2a clinical trial of IMM-1-104 in advanced solid tumors with any RAS mutation Provides debut guidance for IMM-1-104 program: initial Phase 1 PK and safety data expected...
Immuneering-logo (1).png
Immuneering Announces Participation in March Investor Conferences
February 28, 2023 08:00 ET | Immuneering Corporation
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an...
MnM_logo_TM_JPG.JPG
Lung Cancer Surgery Market is Expected to Reach $6.7 billion | MarketsandMarkets.
February 27, 2023 07:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The future of lung cancer surgery is looking promising. Advances in technology and improved understanding of the disease have led to an increase in the...
22157.jpg
Chemotherapy At Home Services Market Research Report 2022: Strategic Partnerships and Collaborations Fueling Market Growth
February 03, 2023 07:33 ET | Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Chemotherapy...
Contrive Datum Insights_Logo.jpg
Computer Aided Diagnostics (CADx) Market Estimated to Grow at a CAGR of 13.3% from 2022 to 2030, Contrive Datum Insights
January 24, 2023 09:49 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The global Computer Aided Diagnostics (CADx) Market size was valued at USD 5.62 Billion in 2022. It is expected to expand at a compound annual growth...
Clinical development based on LC-SCRUM-Asia/AP and  establishment of an international clinico-genomic database for lung cancer
Precision Medicine Asia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic Screening Platform for the Asia-Pacific Region
December 21, 2022 00:00 ET | PREMIA Holdings (HK) Ltd.
TOKYO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Precision Medicine Asia Co., Ltd. (“PREMIA”) and National Cancer Center Hospital East (“NCCHE”) announced the initiation of the Lung Cancer Genomic Screening...
Hairdressers Training Video
The Lung Cancer Foundation of America Launches a New Initiative to Help Hairdressers Provide Potentially Life-Saving Information About Lung Cancer to The Black Community
December 20, 2022 06:00 ET | Lung Cancer Foundation of America
Los Angeles, CA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Lung cancer is a leading cause of death for Black men and women, and research shows that hairdressers are some of the most trusted people in the...
logo.png
Lung Cancer Therapeutics Market Size to Hit USD 55.6 Bn by 2030
December 08, 2022 07:16 ET | Precedence Research
Ottawa, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Precedence Research, recently announced report on “Lung Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional...